Athira Pharma Inc (ATHA)
2.54
-0.17
(-6.27%)
USD |
NASDAQ |
May 17, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
Athira Pharma Total Liabilities (Quarterly): 26.72M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 26.72M |
| December 31, 2023 | 30.06M |
| September 30, 2023 | 29.94M |
| June 30, 2023 | 23.07M |
| March 31, 2023 | 21.65M |
| December 31, 2022 | 23.02M |
| September 30, 2022 | 11.94M |
| June 30, 2022 | 11.45M |
| March 31, 2022 | 11.02M |
| Date | Value |
|---|---|
| December 31, 2021 | 10.92M |
| September 30, 2021 | 11.09M |
| June 30, 2021 | 9.415M |
| March 31, 2021 | 6.197M |
| December 31, 2020 | 5.281M |
| September 30, 2020 | 8.469M |
| June 30, 2020 | 5.512M |
| December 31, 2019 | 21.91M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.281M
Minimum
Dec 2020
30.06M
Maximum
Dec 2023
15.74M
Average
11.45M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Xeris Biopharma Holdings Inc | 345.79M |
| Kodiak Sciences Inc | 193.57M |
| Phathom Pharmaceuticals Inc | 505.00M |
| Arcutis Biotherapeutics Inc | 253.60M |
| Inozyme Pharma Inc | 58.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.46M |
| Shareholders Equity (Quarterly) | 106.74M |